Logo image of VUZI

VUZIX CORP (VUZI) Stock Fundamental Analysis

NASDAQ:VUZI - Nasdaq - US92921W3007 - Common Stock - Currency: USD

1.86  +0.03 (+1.64%)

After market: 1.87 +0.01 (+0.54%)

Fundamental Rating

3

Overall VUZI gets a fundamental rating of 3 out of 10. We evaluated VUZI against 124 industry peers in the Electronic Equipment, Instruments & Components industry. While VUZI has a great health rating, there are worries on its profitability. VUZI is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year VUZI has reported negative net income.
VUZI had a negative operating cash flow in the past year.
In the past 5 years VUZI always reported negative net income.
VUZI had a negative operating cash flow in each of the past 5 years.
VUZI Yearly Net Income VS EBIT VS OCF VS FCFVUZI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

VUZI has a worse Return On Assets (-186.62%) than 96.77% of its industry peers.
VUZI has a Return On Equity of -197.19%. This is amonst the worse of the industry: VUZI underperforms 89.52% of its industry peers.
Industry RankSector Rank
ROA -186.62%
ROE -197.19%
ROIC N/A
ROA(3y)-91.88%
ROA(5y)-68.19%
ROE(3y)-98.06%
ROE(5y)-72.74%
ROIC(3y)N/A
ROIC(5y)N/A
VUZI Yearly ROA, ROE, ROICVUZI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

VUZI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VUZI Yearly Profit, Operating, Gross MarginsVUZI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

8

2. Health

2.1 Basic Checks

VUZI does not have a ROIC to compare to the WACC, probably because it is not profitable.
VUZI has more shares outstanding than it did 1 year ago.
The number of shares outstanding for VUZI has been increased compared to 5 years ago.
VUZI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
VUZI Yearly Shares OutstandingVUZI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
VUZI Yearly Total Debt VS Total AssetsVUZI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

2.2 Solvency

VUZI has an Altman-Z score of 23.81. This indicates that VUZI is financially healthy and has little risk of bankruptcy at the moment.
VUZI's Altman-Z score of 23.81 is amongst the best of the industry. VUZI outperforms 97.58% of its industry peers.
There is no outstanding debt for VUZI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 23.81
ROIC/WACCN/A
WACC8.96%
VUZI Yearly LT Debt VS Equity VS FCFVUZI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 12.65 indicates that VUZI has no problem at all paying its short term obligations.
VUZI has a better Current ratio (12.65) than 94.35% of its industry peers.
VUZI has a Quick Ratio of 10.37. This indicates that VUZI is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 10.37, VUZI belongs to the best of the industry, outperforming 94.35% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 12.65
Quick Ratio 10.37
VUZI Yearly Current Assets VS Current LiabilitesVUZI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

VUZI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.33%, which is quite good.
VUZI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -52.55%.
The Revenue has been decreasing by -2.91% on average over the past years.
EPS 1Y (TTM)17.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
Revenue 1Y (TTM)-52.55%
Revenue growth 3Y-24.1%
Revenue growth 5Y-2.91%
Sales Q2Q%19.22%

3.2 Future

Based on estimates for the next years, VUZI will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.24% on average per year.
VUZI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 44.58% yearly.
EPS Next Y22.68%
EPS Next 2Y12.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year34.86%
Revenue Next 2Y44.58%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
VUZI Yearly Revenue VS EstimatesVUZI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M
VUZI Yearly EPS VS EstimatesVUZI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6 -0.8 -1

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VUZI. In the last year negative earnings were reported.
Also next year VUZI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VUZI Price Earnings VS Forward Price EarningsVUZI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VUZI Per share dataVUZI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 -0.6

4.3 Compensation for Growth

A more expensive valuation may be justified as VUZI's earnings are expected to grow with 12.24% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.24%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for VUZI!.
Industry RankSector Rank
Dividend Yield N/A

VUZIX CORP

NASDAQ:VUZI (4/25/2025, 8:00:01 PM)

After market: 1.87 +0.01 (+0.54%)

1.86

+0.03 (+1.64%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)03-13 2025-03-13/amc
Earnings (Next)05-08 2025-05-08
Inst Owners16.58%
Inst Owner Change0.07%
Ins Owners6.95%
Ins Owner Change-0.14%
Market Cap141.81M
Analysts82.86
Price Target3.06 (64.52%)
Short Float %22.73%
Short Ratio9.66
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-22.55%
Min EPS beat(2)-30.72%
Max EPS beat(2)-14.38%
EPS beat(4)0
Avg EPS beat(4)-28.5%
Min EPS beat(4)-56.86%
Max EPS beat(4)-12.04%
EPS beat(8)1
Avg EPS beat(8)-25.96%
EPS beat(12)2
Avg EPS beat(12)-18.83%
EPS beat(16)2
Avg EPS beat(16)-25.07%
Revenue beat(2)0
Avg Revenue beat(2)-24.59%
Min Revenue beat(2)-30.92%
Max Revenue beat(2)-18.25%
Revenue beat(4)0
Avg Revenue beat(4)-31.48%
Min Revenue beat(4)-58.04%
Max Revenue beat(4)-18.25%
Revenue beat(8)2
Avg Revenue beat(8)-26.92%
Revenue beat(12)2
Avg Revenue beat(12)-22.71%
Revenue beat(16)3
Avg Revenue beat(16)-21.65%
PT rev (1m)0%
PT rev (3m)50%
EPS NQ rev (1m)7.69%
EPS NQ rev (3m)7.69%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-46.55%
Revenue NQ rev (3m)-46.55%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)-0.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 24.64
P/FCF N/A
P/OCF N/A
P/B 3.8
P/tB 4.25
EV/EBITDA N/A
EPS(TTM)-0.62
EYN/A
EPS(NY)-0.48
Fwd EYN/A
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.31
OCFYN/A
SpS0.08
BVpS0.49
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -186.62%
ROE -197.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-91.88%
ROA(5y)-68.19%
ROE(3y)-98.06%
ROE(5y)-72.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 48.85%
Cap/Sales 33.36%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 12.65
Quick Ratio 10.37
Altman-Z 23.81
F-Score4
WACC8.96%
ROIC/WACCN/A
Cap/Depr(3y)371.21%
Cap/Depr(5y)276.01%
Cap/Sales(3y)109.82%
Cap/Sales(5y)75.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
EPS Next Y22.68%
EPS Next 2Y12.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-52.55%
Revenue growth 3Y-24.1%
Revenue growth 5Y-2.91%
Sales Q2Q%19.22%
Revenue Next Year34.86%
Revenue Next 2Y44.58%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y12.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year62.45%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y40.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.66%
OCF growth 3YN/A
OCF growth 5YN/A